ICU kidney patients may need different blood clot doses, new study hints
NCT ID NCT07384598
First seen Feb 03, 2026 · Last updated May 16, 2026 · Updated 14 times
Summary
This study looks at how a blood thinner called enoxaparin works in critically ill patients with kidney failure, some of whom are on a blood-filtering machine. Researchers will measure drug levels in 60 ICU adults to see if standard doses are enough. The goal is to find the right dose to prevent dangerous blood clots.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.